Shares of Eli Lilly (NYSE: LLY) fell sharply on Thursday, dropping more than 11% in regular trading after the company
8 months ago
Drugmakers will ask the U.S. government to pause price negotiations for prescription drugs, Bloomberg News reported on Monday, citing Eli
12 months ago
The U.S. Food and Drug Administration has revoked the emergency use authorization for four COVID-19 antibody-based drugs, including those from
1 year ago
On Friday, the U.S. Food and Drug Administration approved Eli Lilly’s (NYSE: LLY) weight-loss treatment, Zepbound, for obstructive sleep apnea,
SHANGHAI – As Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) expand sales of their popular diabetes and weight-loss
LONDON – Britons paying privately for obesity drugs are increasingly choosing Eli Lilly’s (NYSE: LLY) Mounjaro over Novo Nordisk’s (NYSE:
President-elect Donald Trump met with the chief executives of U.S. drugmakers Pfizer (NYSE: PFE) and Eli Lilly (NYSE: LLY) as
COPENHAGEN – Shares of weight-loss drug makers Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) rose on Tuesday after
Americans are still eagerly seeking prescriptions for Eli Lilly’s (NYSE: LLY) and Novo Nordisk’s (NYSE: NVO) weight-loss and diabetes drugs
NEW YORK – Most U.S. states do not currently cover highly sought-after weight-loss drugs from Novo Nordisk (NYSE: NVO) and
LONDON – Britain will study whether the use of Eli Lilly’s (NYSE: LLY) weight loss drug can get people back
On Monday, a drug compounding industry group sued the U.S. Food and Drug Administration over its decision to take Eli
